Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

150.36
+2.181.47%
Post-market: 150.360.00000.00%19:56 EDT
Volume:2.08M
Turnover:312.18M
Market Cap:286.89B
PE:21.03
High:150.75
Open:150.25
Low:149.56
Close:148.18
52wk High:170.46
52wk Low:97.72
Shares:1.91B
Float Shares:1.82B
Volume Ratio:1.44
T/O Rate:0.11%
Dividend:4.67
Dividend Rate:3.10%
EPS(TTM):7.15
EPS(LYR):7.15
ROE:30.81%
ROA:11.14%
PB:6.22
PE(LYR):21.03

Loading ...

Novartis price target lowered to CHF 132 from CHF 133 at Citi

TIPRANKS
·
Feb 06

Novartis Faces Mounting ESG and Sustainability Risks That Could Weigh on Reputation, Financing, and Long-Term Value

TIPRANKS
·
Feb 05

Novartis Faces Biggest Patent Expiry Ever but Sees Growth Ahead

Benzinga
·
Feb 05

Novartis reports Q4 core EPS $2.03 vs. $1.98 last year

TIPRANKS
·
Feb 04

Dow Jones Top Company Headlines at 7 AM ET: Wegovy Maker Novo Nordisk's Shares Slump After Guidance Disappoints | GE ...

Dow Jones
·
Feb 04

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S. -- Update

Dow Jones
·
Feb 04

Novartis 2026 Guidance a Bit Soft on Earnings -- Market Talk

Dow Jones
·
Feb 04

Generic Drug Competition Intensifies, Novartis Forecasts 2026 Profit Decline

Stock News
·
Feb 04

Novartis Expects Low Single-Digit Decline in 2026 Operating Profit

Reuters
·
Feb 04

Novartis Q4 Adj. EPS $1.26 Misses $1.99 Estimate, Sales $13.336B Miss $13.781B Estimate

Benzinga
·
Feb 04

Novartis Guidance in Focus as Drug Patent Losses Loom -- Earnings Preview

Dow Jones
·
Feb 03

Novartis AG Rises Friday

Dow Jones
·
Jan 31

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Jan 30

Novartis (NVS.US) siRNA Therapy "Inclisiran" Approved for New Indication

Stock News
·
Jan 28

Medicare is about to start negotiating the prices of medications administered by doctors

Dow Jones
·
Jan 28

Earning Preview: Novartis AG Q4 revenue is expected to increase by 5.72%, and institutional views lean positive

Earnings Agent
·
Jan 28

BRIEF-CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program

Reuters
·
Jan 28

Novartis AG Rises Tuesday

Dow Jones
·
Jan 28

Top Calls on Wall Street: Apple, Tesla, Nvidia, Amazon, CoreWeave, Strategy, Disney, and More

Tiger Newspress
·
Jan 27

Novartis Positions US Strategy As Defense Against Rising Trade Levies

Benzinga_recent_news
·
Jan 23